This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Attention-Deficit/Hyperactivity Disorder (ADHD)
and you are
between 18 and 25
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The purpose of the proposed study is to determine the effectiveness of methylphenidate HCl (Concerta) in college students with ADHD. This study will consist of 110 college students between the ages of 18 and 25 who are enrolled full-time in a local or junior college. The study consists of an 8-week double-blind, placebo-controlled trial of placebo versus methylphenidate HCl (Concerta®) followed by a 10-week extension of open label methylphenidate HCl (Concerta®).

Provided treatments

  • Drug: methylphenidate HCl (Concerta)
  • Drug: Placebo
Tris trial is registered with FDA with number: NCT00931398. The sponsor of the trial is University of Pittsburgh and it is looking for 0 volunteers for the current phase.
Official trial title:
Treatment of College Students With ADHD Using OROS Methylphenidate